Alfie Brennan

Company: Evariste

Job title: Chief Scientific Officer

Seminars:

Enhancing Translation of PKMYT1 Targeting: In Vivo & In Vitro Strategies for Maximizing Efficacy & Patient Impact 10:30 am

Conducting comparative analysis of the in vitro profile of Evariste’s preclinical candidate PKMYT1 inhibitor, EVT-3023 Analyzing of the extent to which PKMYT1 is responsible for control of pCDK1 levels in various in vitro and in vivo models Exploring translation of a novel biomarker for sensitivity to PKMYT1 inhibitionRead more

day: Day Two